ArticleBMC veterinary research2026
Improved RNA-based metagenomic sequencing for rapid pathogen detection in pets.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
In veterinary medicine, particularly in pet clinics, the accurate and rapid detection of pathogens is crucial for effective disease diagnosis and treatment. Traditional diagnostic methods are often time-consuming and fall short in identifying a broad spectrum of pathogens. The newly developed metagenomic transcriptomics next-generation sequencing (mtNGS) technology is a promising tool for the rapid detecting RNA- and DNA-based pathogens. However, its application in pet clinics has been limited due to high costs, complex operational procedures, and the absence of unified protocols. Here we established a standardized mtNGS workflow for pathogen detection tailored to various clinical sample types from pets. This workflow involves the extraction of total RNA without rRNA depletion and sequencing using Illumina platforms. It also incorporates Bowtie2 to eliminate host genome sequences and MetaPhlAn3 to identify microbial compositions. Our mtNGS technology was evaluated in 16 diverse clinical cases involving body fluids, fecal samples, nasopharyngeal swabs, and tissue samples from dogs, cats, and parrots. Notably, it detected pathogens in all cases, including an identification of Mycobacterium intracellulare in a cat, highlighting its utility in diagnosing zoonotic diseases. These results, corroborated by traditional techniques, demonstrate that the mtNGS-based diagnostic approach is particularly advantageous in cases where conventional diagnostics are insufficient or when multiple co-infections are suspected. This method exhibits potential in diagnosing complex clinical diseases that are challenging to identify using traditional techniques, thus representing a promising tool and can be widely applied in veterinary diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.